Submission Details
| 510(k) Number | K140141 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 22, 2014 |
| Decision Date | July 03, 2014 |
| Days to Decision | 162 days |
| Submission Type | Special |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K140141 is an FDA 510(k) clearance for the LABONACHECK GLUPPY BLOOD GLUCOSE MONITORING SYSTEM, a System, Test, Blood Glucose, Over The Counter (Class II — Special Controls, product code NBW), submitted by Ceragem Medisys, Inc. (Cheonan, Chungcheongnam-Do, KR). The FDA issued a Cleared decision on July 3, 2014, 162 days after receiving the submission on January 22, 2014. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1345.
| 510(k) Number | K140141 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 22, 2014 |
| Decision Date | July 03, 2014 |
| Days to Decision | 162 days |
| Submission Type | Special |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | NBW — System, Test, Blood Glucose, Over The Counter |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1345 |